Regulation of perfluorooctanoic acid-induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones
Open Access
- 1 February 1992
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 15 (2) , 316-322
- https://doi.org/10.1002/hep.1840150223
Abstract
A wide variety of compounds, including hypolipidemic drugs, plasticizers and other industrial chemicals, have been found to cause liver enlargement and hepatic peroxisome proliferation by mechanisms that are unclear. Although thyroid and sex hormones have been shown to modulate the hepatic response to these chemicals, the role of adrenal hormones in these phenomena is not clear, and a few studies have produced conflicting data. Therefore this study was undertaken to investigate the role of adrenal hormones in hepatomegaly and peroxisomal enzyme induction caused by peroxisomal proliferators and to further delineate the interrelationship between these parameters. Because adrenalectomy alters hepatic drug metabolism, we have used the nonmetabolizable proliferator perfluorooctanoic acid. Our data show that hepatomegaly caused by perfluorooctanoic acid depends on corticosterone, the major glucocorticoid in rodents. Liver growth caused by perfluorooctanoic acid appears to be predominantly hypertrophic in nature, and DNA synthesis in response to perfluorooctanoic acid predominates in periportal regions of the liver lobule. Data also show that although induction of peroxisomal β-oxidation by perfluorooctanoic acid is independent of adrenal hormones, induction of catalase is dependent on the presence of these hormones. This study supports the contention that induction of activities of various peroxisomal enzymes is controlled by different regulatory mechanisms.Keywords
This publication has 29 references indexed in Scilit:
- Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen: Carcinogen pair—2,6- and 2,4-diaminotolueneToxicology and Applied Pharmacology, 1991
- Factors which may be significant regarding regulation of the clofibrate-dependent induction of hepatic peroxisomal β-oxidation and hepatomegalyBiochemical Pharmacology, 1984
- Differential effects of altered hormonal state on the induction of ACYL-CoA hydrolases and peroxisomal β-oxidation by clofibric acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to HumansCRC Critical Reviews in Toxicology, 1983
- Induction of hepatic ornithine decarboxylase by hypolipidemic drugs with hepatic peroxisome proliferative activityCarcinogenesis: Integrative Cancer Research, 1981
- Enhancement of Fatty Acyl-CoA Oxidizing Activity in Rat Liver Peroxisomes by Di-(2-Ethylhexyl)PhthalateThe Journal of Biochemistry, 1978
- A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.Proceedings of the National Academy of Sciences, 1976
- CatalasePublished by Elsevier ,1974
- Use of 3H-thymidine for measurement of DNA synthesis in rat liver—a warningAnalytical Biochemistry, 1972
- MICROBODIES IN EXPERIMENTALLY ALTERED CELLSThe Journal of cell biology, 1969